{"ok":true,"trend":{"id":772916,"platform":"news","region":"global","key":"fda to highlight aging, longevity medicine in planned fars update","title":"FDA to Highlight Aging, Longevity Medicine in Planned FARS Update","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPeXdWOFYwWlJ4ek1oMnJ4V0l6a1VMSzFVc3dOZF96U2pYeG53VEtMaHpXUy10OUh6ZFlkYjN2OUJ4SjMyU2xQSzlMaWZWZ014VUFYTjduVkl5WkNzUFVwT0FMT2ItclFFcVFnbU9VTy10LTg4a2czaWJFSHVKVlhFeUNuWjZDVVZ2ZVVGSjFhQkp0bWRWZ0ZVMkxVaWhWV2hTeW5fcmM0bVZqQWU3UVB4QXlDVDFjNm9QcjJ5eFRfQQ?oc=5","first_seen":"2026-10-02T20:03:13.067387Z","last_seen":"2026-10-03T00:10:32.411441Z","last_rank":24,"peak_rank":12,"last_volume":null,"peak_volume":0,"seen_count":4,"score":0.990625,"category_hint":"medicine","section":"health","category":"medicine","summary":"The FDA plans to use an upcoming FARS update to emphasize aging and longevity medicine, signaling growing regulatory attention to treatments targeting age-related disease. The move was reported by Genetic Engineering and Biotechnology News. Observers see it as a sign that longevity science is moving closer to mainstream regulatory priorities, with implications for drug developers and biotech firms working on aging-related therapies.","why":"Regulators signaling interest in longevity medicine matters to biotech firms and investors tracking the fast-growing aging-research field.","tone":"neutral","entities":["FDA","FARS","Genetic Engineering and Biotechnology News"],"summarized_at":"2026-10-03T02:05:38.676126Z","meta":{"via":"scan","lang":"en","term":"medicine","source":"Genetic Engineering and Biotechnology News","published":"Fri, 02 Oct 2026 18:39:14 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"FDA to Spotlight Aging and Longevity Medicine in FARS Update","section_name":"Health","category_name":"Medicine","timeline":[{"captured_at":"2026-10-02T20:03:13.067387Z","rank":12,"volume":null},{"captured_at":"2026-10-02T21:25:32.655435Z","rank":13,"volume":null},{"captured_at":"2026-10-02T22:47:33.001784Z","rank":18,"volume":null},{"captured_at":"2026-10-03T00:10:32.411441Z","rank":24,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxPeXdWOFYwWlJ4ek1oMnJ4V0l6a1VMSzFVc3dOZF96U2pYeG53VEtMaHpXUy10OUh6ZFlkYjN2OUJ4SjMyU2xQSzlMaWZWZ014VUFYTjduVkl5WkNzUFVwT0FMT2ItclFFcVFnbU9VTy10LTg4a2czaWJFSHVKVlhFeUNuWjZDVVZ2ZVVGSjFhQkp0bWRWZ0ZVMkxVaWhWV2hTeW5fcmM0bVZqQWU3UVB4QXlDVDFjNm9QcjJ5eFRfQQ?oc=5","author":"Genetic Engineering and Biotechnology News","title":"FDA to Highlight Aging, Longevity Medicine in Planned FARS Update","snippet":null,"posted_at":"2026-10-02T18:39:14Z","likes":null}],"elsewhere":[],"window":"7d"}}